Oppenheimer analyst Rick Schafer is keeping his Perform rating on NXP Semiconductors after the company reduced its expectations for Q1 due to coronavirus, noting that while the impact remains difficult to quantify due to the fluidity of the situation, he also sees it as being transitory. The analyst also cites high macro uncertainty behind his neutral stance, adding that after a 7% year-to-date decline in the stock price, NXP Semiconductors' current valuation of 13-times his expected forward earnings is at the midpoint of its historical range.

Susquehanna analyst Christopher Rolland raised the firm's price target on Impinj (PI) to $150 from $140 and keeps a Positive rating on the shares. The firm said they posted a solid print with additional upside driven by the licensing win from NXP Semiconductors (NXPI). Customer engagements and new RFID markets continue to broaden the opportunity.

BofA raised the firm's price target on Texas Instruments (TXN) to $190 from $175 and keeps a Neutral rating on the shares. TI's small Q1 beat and inline but sequentially rising Q2 sales guidance, "while modest, potentially marks a recovery inflection in industrial chip demand," with positive read-across for U.S. peers such as Analog Devices (ADI), Microchip (MCHP), NXP Semiconductors (NXPI) and On Semiconductor (ON), the analyst tells investors. However, despite an expected recovery, TI's sustained high capex intensity could keep reported calendar year 2024-26 pro-forma EPS below $6 per share, the analyst added.